10-70674751-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080722.4(ADAMTS14):c.278G>A(p.Gly93Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,613,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080722.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS14 | NM_080722.4 | c.278G>A | p.Gly93Glu | missense_variant | 2/22 | ENST00000373207.2 | NP_542453.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS14 | ENST00000373207.2 | c.278G>A | p.Gly93Glu | missense_variant | 2/22 | 1 | NM_080722.4 | ENSP00000362303 | P4 | |
ADAMTS14 | ENST00000373208.5 | c.278G>A | p.Gly93Glu | missense_variant | 2/22 | 2 | ENSP00000362304 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000561 AC: 14AN: 249762Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135332
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461130Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 726854
GnomAD4 genome AF: 0.000210 AC: 32AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2021 | The c.278G>A (p.G93E) alteration is located in exon 2 (coding exon 2) of the ADAMTS14 gene. This alteration results from a G to A substitution at nucleotide position 278, causing the glycine (G) at amino acid position 93 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at